•
VR
VRAX
Virax Biolabs Group Limited Ordinary Shares
polygon--
Price Chart
Market Cap
2.12M
Volume
495.30K
52W High
$2.33
52W Low
$0.26
Open
$0.30
Prev Close
$0.29
Day Range
0.26 - 0.30
About Virax Biolabs Group Limited Ordinary Shares
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
Latest News
Virax Biolabs Group Limited Announces $5 Million Private Placement
Benzinga•Dec 3
Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration
GlobeNewswire Inc.•Jun 21
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
Benzinga•Sep 16
Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Benzinga•Jan 16
Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
Benzinga•Jan 3
Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga•Dec 28
Penny Stocks To Buy Before 2024? 3 For Your Watch List Now
PennyStocks•Dec 27
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga•Dec 27